Clinical Trials
All Clinical Trials - Page 69 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00182754Phase 3Completed
Octreotide in Treating Patients With Cancer-Related Malignant Ascites
Octreotide
- NCT00240045Phase 2/Phase 3Completed
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
Octreotide
- NCT00217659Phase 2Withdrawn
S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
Gonadorelin
- NCT00229658N/ACompleted
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
Pramlintide
- NCT00189514Phase 2Completed
A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Pramlintide
- NCT00668941Phase 2Unknown
Cyclic Versus Daily Teriparatide on Bone Mass
Teriparatide
- NCT00239629Phase 4Completed
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
Teriparatide
- NCT00221299Phase 4Completed
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
Teriparatide
- NCT00222092N/ACompleted
Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers
Octreotide
- NCT00332969Phase 2Completed
Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma
Octreotide
- NCT00332696Phase 2Completed
Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
Octreotide
- NCT01613495N/AUnknown
Ghrelin Suppression by Octreotide in Prader-Willi
Octreotide
- NCT00375687N/AUnknown
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer
Gonadorelin
- NCT00225420Phase 1/Phase 2Completed
Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer
Gonadorelin
- NCT01508806Phase 1Completed
Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function
Liraglutide
- NCT00228943N/ACompleted
The Role of Serotonin in Hot Flashes After Breast Cancer
KPV
- NCT00123110Phase 2Completed
Insulin Resistance and Testosterone in Women
Gonadorelin
- NCT00257426Phase 2Completed
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Octreotide
- NCT02012166Phase 1Completed
A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002)
Octreotide
- NCT00123253Phase 3Completed
TH9507 in Patients With HIV-Associated Lipodystrophy
Tesamorelin
- NCT01005784Phase 4Completed
Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation
Gonadorelin
- NCT00131469Phase 4Completed
Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta
Teriparatide
- NCT00804297Phase 3Completed
Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia
Octreotide
- NCT00522743N/ACompleted
Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.
Gonadorelin
- NCT01076335Phase 2Completed
Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer
Gonadorelin
- NCT00112021Phase 2Completed
A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
Pramlintide
- NCT00742339Phase 2/Phase 3Terminated
Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome
Octreotide
- NCT01014793N/ACompleted
Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients
Octreotide
- NCT00196846Phase 2Completed
Prevention of Chemotherapy Induced Ovarian Failure With Goserelin in BC Patients (ZORO)
Gonadorelin
- NCT00161421Phase 2Completed
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
Gonadorelin
- NCT00296465Phase 2/Phase 3Completed
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
Gonadorelin
- NCT00103935Phase 2Completed
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
Exenatide
- NCT00191867Phase 2Completed
Clinical Trial of Teriparatide in Japan
Teriparatide
- NCT00171613Phase 4Completed
A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients
Octreotide
- NCT01514487Phase 1Completed
Comparison of Three Liraglutide Formulations in Healthy Volunteers
Liraglutide
- NCT00172185Phase 3Completed
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
Teduglutide
- NCT00800930Phase 2Completed
Therapeutic Induction of Endogenous Antibiotics
Ll-37
- NCT01037699Phase 3Completed
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
Gonadorelin
- NCT00154414Phase 2Completed
Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes
Liraglutide
- NCT00154401Phase 2Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00517283Phase 1Completed
A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
Exenatide
- NCT00489645N/ACompleted
Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide
Pramlintide
- NCT00444873Phase 3Completed
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
Lanreotide
- NCT01029275N/ACompleted
Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone
Octreotide
- NCT00113360Phase 2Completed
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
Octreotide
- NCT00635310N/AUnknown
Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Desmopressin
- NCT01178996Phase 3Completed
Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.
Thymosin-Alpha-1
- NCT00190944Phase 2Completed
Effects of Teriparatide on Distal Radius Fracture Healing
Teriparatide
- NCT00209261Phase 4Completed
A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
Desmopressin
- NCT00566813Phase 1/Phase 2Completed
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
Exenatide